Table 1.
Expression profile of intratumoral CD45+Rab37+IL6+ levels in relation to clinicopathological parameters in 62 NSCLC patients
| Clinicopathologic parameters | CD45+Rab37+IL6+ cells (%)a | p valueb | ||
|---|---|---|---|---|
| Total | Low (%) (66.1%) | High (%) (33.9%) | ||
| N = 62 | N = 41 | N = 21 | ||
| Stage | ||||
| Stage I-II | 32 | 28 (87.5) | 4 (12.5) | |
| Stage III-IV | 30 | 13 (43.3) | 17 (56.7) | < 0.001 |
| N stagec | ||||
| N0 | 27 | 22 (81.5) | 5 (18.5) | |
| N ≥ 1 | 35 | 19 (54.3) | 16 (45.7) | 0.025 |
| M stagec | ||||
| M0 | 53 | 39 (73.6) | 14 (26.4) | |
| M ≥1 | 9 | 2 (22.2) | 7 (77.8) | 0.003 |
a Categorical data were presented as the mean.
b The data were analyzed by Pearson χ2 test.
c N Stage: lymph node metastasis; M Stage: distal organ metastasis.